CXCL12/CXCR4-Rac1–mediated migration of osteogenic precursor cells contributes to pathological new bone formation in ankylosing spondylitis

H Cui, Z Li, S Chen, X Li, D Chen, J Wang, Z Li… - Science …, 2022 - science.org
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by inflammatory
back pain and spinal ankylosis due to pathological new bone formation. Here, we identified …

CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro

X Feng, S Zhu, J Qiao, Z Ji, B Zhou, W Xu - Journal of Translational …, 2023 - Springer
Background Ankylosing spondylitis (AS) is an autoimmune disease with a genetic
correlation and is characterized by inflammation in the axial skeleton and sacroiliac joints …

Abnormal inhibition of osteoclastogenesis by mesenchymal stem cells through the miR-4284/CXCL5 axis in ankylosing spondylitis

W Liu, P Wang, Z Xie, S Wang, M Ma, J Li, M Li… - Cell Death & …, 2019 - nature.com
Ankylosing spondylitis (AS) is a common inflammatory autoimmune disease, characterized
by pathological osteogenesis. Mesenchymal stem cells (MSCs), as the main source of …

HLA-B27–mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis

CH Liu, S Raj, CH Chen, KH Hung… - The Journal of …, 2019 - Am Soc Clin Investig
Ankylosing spondylitis (AS) is a type of axial inflammation. Over time, some patients develop
spinal ankylosis and permanent disability; however, current treatment strategies cannot …

MCP1 triggers monocyte dysfunctions during abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis

Z Xie, P Wang, J Li, Y Li, S Wang, X Wu, S Sun… - Journal of Molecular …, 2017 - Springer
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by pathological
osteogenesis and inflammation. However, the pathogenesis of AS and the pathological …

Aberrant upregulation of CaSR promotes pathological new bone formation in ankylosing spondylitis

X Li, S Chen, Z Hu, D Chen, J Wang, Z Li… - EMBO Molecular …, 2020 - embopress.org
Pathological new bone formation is a typical pathological feature in ankylosing spondylitis
(AS), and the underlying molecular mechanism remains elusive. Previous studies have …

Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis

F Shao, Q Liu, Y Zhu, Z Fan, W Chen, S Liu, X Li… - Nature …, 2021 - nature.com
Bony fusion caused by pathological new bone formation manifests the clinical feature of
ankylosing spondylitis (AS). However, the underlying mechanism remains elusive. Here we …

Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification

T Yu, J Zhang, W Zhu, X Wang, Y Bai, B Feng… - Bone Research, 2021 - nature.com
Ankylosing spondylitis (AS) is chronic inflammatory arthritis with a progressive fusion of axial
joints. Anti-inflammatory treatments such as anti-TNF-α antibody therapy suppress …

Enhanced osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis: a study based on a three-dimensional biomimetic environment

G Zheng, Z Xie, P Wang, J Li, M Li, S Cen, S Tang… - Cell death & …, 2019 - nature.com
The mechanism of pathological osteogenesis in Ankylosing spondylitis (AS) is largely
unknown. Our previous studies demonstrated that the imbalance between BMP-2 and …

CXCL8 and CCL20 enhance osteoclastogenesis via modulation of cytokine production by human primary osteoblasts

JL Pathak, AD Bakker, P Verschueren, WF Lems… - PloS one, 2015 - journals.plos.org
Generalized osteoporosis is common in patients with inflammatory diseases, possibly
because of circulating inflammatory factors that affect osteoblast and osteoclast formation …